Il-yang Pharm. Co., Ltd.

This study tests a new quadrivalent seasonal flu vaccine in healthy infants aged 6 months to under 3 years. The goal is to see if the vaccine is safe and triggers a strong immune response. About 245 infants will receive either the new vaccine or an existing one, and their antibod…